Paul ChapmanBSc, PhD

Partner

Chartered (UK) and European Patent Attorney

Offices: Edinburgh (UK)

Languages spoken: English

Email: pchapman@marks-clerk.com

Telephone (Office): +44 131 221 7000

Download vCard

linkedin

Paul Chapman

Paul is a Chartered (UK) and European with over 20 years of experience in the IP profession. A number of his clients have worked with him since he started in the profession and still do so to this day. His clients range from universities and SMEs to large multinational companies particularly in the biotechnology, chemistry and pharmaceutical fields.

He has significant expertise in biologics including, antibody technology, cell therapies, RNAi and vaccines. Paul also carries out a significant amount of work in relation to molecular diagnostics, medical devices, anaerobic digestion, drug delivery, cancer therapeutics, catalysis, nanotechnology and DNA technologies. He has experience of European Opposition and Appeal procedures, in particular, in the areas of biotechnology, molecular biology and chemistry. Paul also has considerable experience of filing and prosecuting SPC applications throughout Europe. As well as prosecution and opposition work, Paul provides strategic advice to ensure that his clients get the best out of their IP.

Paul is Managing Partner of the firm's Edinburgh office and also chair of Marks & Clerk's Life Sciences committee, having authored and/or edited a number of the firm's life sciences reports and other publications. Paul is a regular speaker at bioscience conferences and has given many presentations and workshops to universities and other clients.

Paul was recommended in 2016 by IAM Patent 1000, which says that “he constantly provides excellent service”. He was recommended in the 2015 edition of Legal 500, and mentioned in 2016. Paul was also listed in 2016 as an ‘IP Star’ by Managing Intellectual Property.

Paul was brought up and educated in Edinburgh. He obtained an honours degree in microbiology from the University of Glasgow, followed by a doctorate in molecular biology.

Paul Chapman works in the following sectors

Biotechnology
Chemical
Food
Materials
Medical devices
Nanotechnology
Pharmaceutical
.
Articles

Medtech is key in fight against AMR

Antimicrobial resistance remains one of the key healthcare challenges of our time. 

POSTED 21 May 2018
.
Our news

UK trade mark and patents practices remain tier 1 in Legal 500

POSTED 18 September 2015

You may also be interested in...

.
Brexit & Intellectual Property
Article

Brexit & Intellectual Property

Current information on Brexit

.
Articles

The European Commission’s “export manufacturing waiver” to SPCs

POSTED 13 July 2018
.
Our news

Finalists for the Oxford Trust Enterprise Awards 2018 announced

POSTED 6 July 2018

Find the right person

Find the office that suits you

Click here to view our offices

>